购物车
0
有库存
HIT212650505
 sdf 文件
结构编辑
类似物检索
HIT212650505
  • HIT ID:HIT212650505
  • Cas No:936623-90-4
  • 常用名:Sacubitril/Valsartan
  • 别名:沙库必曲/缬沙坦, Valsartan, Sacubitril mixture with Valsartan, Sacubitril, LCZ696
    别名:沙库必曲/缬沙坦, Valsartan, Sacubitril mixture with Valsartan, Sacubitril, LCZ696
  • IUPAC:hexasodium bis(5-(4'-{[N-(1-carboxylato-2-methylpropyl)pentanamido]methyl}-[1,1'-biphenyl]-2-yl)-2H-1,2,3,4-tetrazol-2-ide) bis(3-[(1-{[1,1'-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl)carbamoyl]propanoate) pentahydrate
    IUPAC:hexasodium bis(5-(4'-{[N-(1-carboxylato-2-methylpropyl)pentanamido]methyl}-[1,1'-biphenyl]-2-yl)-2H-1,2,3,4-tetrazol-2-ide) bis(3-[(1-{[1,1'-biphenyl]-4-yl}-5-ethoxy-4-methyl-5-oxopentan-2-yl)carbamoyl]propanoate) pentahydrate
  • InChI key:PVRKRUBVWABOKS-UHFFFAOYSA-H
  • 分子式:C96H126N12Na6O21
  • 分子量:1922.066
  • 氢键供体数 (HBD):0
  • 氢键受体数 (HBA):7
  • LogP:5.269379
  • SMILES:O.O.O.O.O.[NaH+].[NaH+].[NaH+].[NaH+].[NaH+].[NaH+].CCOC(=O)C(C)CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC([O-])=O.CCOC(=O)C(C)CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC([O-])=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[n-]n1)C(C(C)C)C([O-])=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[n-]n1)C(C(C)C)C([O-])=OjcExt:v:5:1,6:1,7:1,8:1,9:1,10:1
    SMILES:O.O.O.O.O.[NaH+].[NaH+].[NaH+].[NaH+].[NaH+].[NaH+].CCOC(=O)C(C)CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC([O-])=O.CCOC(=O)C(C)CC(Cc1ccc(cc1)-c1ccccc1)NC(=O)CCC([O-])=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[n-]n1)C(C(C)C)C([O-])=O.CCCCC(=O)N(Cc1ccc(cc1)-c1ccccc1-c1nn[n-]n1)C(C(C)C)C([O-])=OjcExt:v:5:1,6:1,7:1,8:1,9:1,10:1
  • Sacubitril/Valsartan (LCZ696),以1:1摩尔比由Valsartan(一种ARB)和Sacubitril(AHU377)组成,为创新口服血管紧张素受体-脑啡肽酶(ARN)双重抑制剂,旨在治疗高血压与心力衰竭。其作用机制包括抑制炎症、氧化应激及细胞凋亡,有助于改善糖尿病心肌病。
市场产品/服务共显示1个结果
  • 供应商
    TargetMolSC
    规格
    货期
    1-3天
    纯度
    99.94%
    ¥ 283.00
    1

寻找合适的化合物库

您无法确定哪种化合物库最适合您的项目?或者您需要定制解决方案?Anymole随时为您提供帮助。
电话:400820-0310
合作:info@screeningcompound.com
技术支持:tech@screeningcompound.com
客服:service@screeningcompound.com
TargetMol | Target Loading
正在加载 ~